Stockscreener 앱 받기
0.795
2.58%
0.02
시간 외 거래:
.78
-0.015
-1.89%
전일 마감가:
$0.775
열려 있는:
$0.78
하루 거래량:
100.29K
Relative Volume:
0.98
시가총액:
$4.02M
수익:
-
순이익/손실:
$-736.70K
주가수익비율:
-79.50
EPS:
-0.01
순현금흐름:
$-4.14M
1주 성능:
+9.58%
1개월 성능:
-7.59%
6개월 성능:
-10.55%
1년 성능:
-51.52%
1일 변동 폭
$0.75
$0.80
1주일 범위
$0.7261
$0.82
52주 변동 폭
$0.6608
$2.9799
Xortx Therapeutics Inc Stock (XRTX) Company Profile
XRTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XRTX
Xortx Therapeutics Inc
|
0.795 | 3.72M | 0 | -736.70K | -4.14M | -0.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Xortx Therapeutics Inc 주식(XRTX)의 최신 뉴스
Custom watchlist performance reports with XORTX Therapeutics Inc.Weekly Setup Summary for Risk Controlled Trades - Newser
What Fibonacci levels say about XORTX Therapeutics Inc. reboundMarket Liquidity and Price Flow Analysis - Newser
Should you hold or exit XORTX Therapeutics Inc. nowChart Driven Entry Timing for Swing Trades - Newser
XORTX Therapeutics Completes $114,500 Private Placement to Fund Gout Programs - MSN
How XORTX Therapeutics Inc. stock performs during market volatilitySafe Investment Ideas with Growth Upside - Newser
Is XORTX Therapeutics Inc. stock poised for growthReversal Pattern Insights with Entry Tips - Newser
Leading vs lagging indicators on XORTX Therapeutics Inc. performanceFree Entry Alert Based on Volume Spikes - Newser
Is XORTX Therapeutics Inc. stock overhyped or has real potentialFree Breakout Entry Signal Confirmation Tool - Newser
Combining price and volume data for XORTX Therapeutics Inc.Earnings Based Stock Performance Forecast - Newser
Using R and stats models for XORTX Therapeutics Inc. forecastingFree Consistent Income Focused Trade List - Newser
Sector ETF performance correlation with XORTX Therapeutics Inc.Momentum Trading Guide with Safety Limits - Newser
XORTX Completes USD $114,500 Private Placement - GlobeNewswire
XORTX Completes USD $114,500 Private Placement - GlobeNewswire Inc.
How sentiment analysis helps forecast XORTX Therapeutics Inc.Predictive Short-Term Market Reversal Alerts - Newser
Volume spikes in XORTX Therapeutics Inc. stock – what they meanTriple Digit Gain Opportunity Watchlist - Newser
Using fundamentals and technicals on XORTX Therapeutics Inc.Long-Term Growth Trend Summary With Confidence - Newser
Smart tools for monitoring XORTX Therapeutics Inc.’s price actionFast Return Equity Forecast With Logic - Newser
Xortx Therapeutics announces planned goals for 2026 - TipRanks
XORTX Therapeutics Advances Gout Program with Strategic 2025/2026 Goals - TipRanks
XORTX Provides Corporate Update and Planned Activities for 2025 / 2026 - GlobeNewswire
Chart overlay techniques for tracking XORTX Therapeutics Inc.Momentum Screener with Buy and Sell Areas - Newser
Is this a good reentry point in XORTX Therapeutics Inc.Momentum Stocks with Breakout Potential - Newser
Will XORTX Therapeutics Inc. continue its uptrendSmart Chart Forecasting with AI Algorithms - Newser
Can technical indicators confirm XORTX Therapeutics Inc.’s reversalConsistent Profit Signals with AI Models - Newser
Will earnings trigger a reversal in XORTX Therapeutics Inc.Low Risk High Confidence Watchlist Builder - Newser
Recovery Setup Building in XORTX Therapeutics Inc. Experts SayWeekly Watchlist of High Movers Released - beatles.ru
XORTX Therapeutics Inc. stock retracement – recovery analysisIntraday Price Forecast Using Volume Models - Newser
Bull of the Day: Netflix, Inc. (NFLX) - The Globe and Mail
XORTX Therapeutics Inc. stock chart pattern explainedSafe Entry Screening with Data Backed Analysis - Newser
McEwen Q2 2025 Results Conference Call - The Globe and Mail
Baker Hughes & Chart Ink $13.6B Deal—Start of Energy's Comeback? - The Globe and Mail
Why is XORTX Therapeutics Inc. stock attracting strong analyst attentionFree Wealth Management Insights - Jammu Links News
How volatile is XORTX Therapeutics Inc. stock compared to the marketDouble or triple returns - Jammu Links News
What are the latest earnings results for XORTX Therapeutics Inc.Build wealth with high-performing stocks - Jammu Links News
What are analysts’ price targets for XORTX Therapeutics Inc. in the next 12 monthsPhenomenal capital gains - Jammu Links News
Xortx Therapeutics Inc (XRTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):